Delivery Order SPE2DB20D1004-SPE2DB23FF8N8
- Not listed
- This federal contract award, valued at $1,325.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet 50-1,000 mg Tablets, a medication used to treat type 2 diabetes. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,276.84 firm fixed-price delivery order is for Janumet 50-1,000 mg tablets, a diabetes medication. The contract has an ultimate completion date of May 9, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,955.70 firm fixed-price delivery order is for the supply of Janumet 50-1,000 mg tablets, a diabetes medication. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order valued at $4,581.31 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,221.58 delivery order is for the supply of Janumet 50-1,000 mg tablets. The contract has an ultimate completion date of December 16, 2022 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $17,090.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the provision of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 7, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,185.91 fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat diabetes. The contract has an ultimate completion date of November 1, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $13,001.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. This is a firm fixed-price delivery order contract with a completion date of December 29, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,352.37 firm fixed-price delivery order is for Janumet 50-1,000 mg tablets, a medication used for the treatment of type 2 diabetes. The contract has an ultimate completion date of November 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,086.66 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF8N8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,524.70 delivery order contract is for the procurement of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a period of performance through May 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award was made through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 5/10/23 |